Skip to main content
Clinical Trials/JPRN-jRCTs041180059
JPRN-jRCTs041180059
Recruiting
Phase 3

A randomized control trial of conditioning regimen of cord blood transplantation for adult myeloid malignancies comparing CA/CY/TBI with vs without G-CSF priming - G-CONCORD

Terakura Seitaro0 sites108 target enrollmentFebruary 28, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute myelogenous leukemia or myelodysplastic syndrome
Sponsor
Terakura Seitaro
Enrollment
108
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Terakura Seitaro

Eligibility Criteria

Inclusion Criteria

  • 1\.First stem cell transplantation including autologous or allogeneic.
  • 2\.Hematological disease listed below.
  • \-Acute myelogenous leukemia
  • \-Myelodysplastic syndrome, RAEB\-1 or RAEB\-2\. Either intermediate\-II or high in IPSS. High or very\-high in WPSS. Relapsed after CR.
  • 3\.Obtained informed consent
  • 4\.Performance status 0,1,2
  • 5\.appropriate cord blood is available
  • 6\.appropriate organ function

Exclusion Criteria

  • 1\.HBs antigen positive
  • 2\.HCV antibody positive
  • 3\.HIV antibody positive
  • 4 Donor\-specific anti\-HLA antibody positive
  • 5\.Use of gemtuzumab ozogamicin within 6 months before transplantation
  • 6\.During pregnant or breast\-feeding
  • 7\. Uncontrollable psychiatric disorder
  • 8\. Uncontrollable infection
  • 9\. Allergy for any drug used in the conditioning regimen or GVHD\-prophylaxis
  • 10\.Considered to be unfit for the study enrollment by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials